Zusammenfassung
In diesem Kapitel wird ein Überblick über die Entwicklung und Funktionsweise verschiedener Systeme zur mechanischen Kreislaufunterstützung gegeben. Die Indikationen für den Einsatz dieser Systeme, die Interaktionen zwischen Patienten und Device und die daraus resultierenden möglichen Komplikationen sind weitere Inhalte dieses Abschnittes. Die Implantationstechnik eines modernen Devices wird detailliert beschrieben, ebenso das perioperative Patientenmanagement sowie die Behandlung der Patienten im Langzeitverlauf.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsLiteratur
Aaronson KD, Schwartz JS, Chen TM et al (1997) Development and prospective evaluation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. Circulation 95:2660–2667
Abrams D, Garan AR, Abdelbary A et al (2018) Position paper for the organization of ECMO programs for cardiac failure in adults. Intensive Care Med. 2018;44:717–729
Basra SS, Attallab AA, Wagle R et al (2009) Infections in patients on continuous flow LVAD: epidemiology and role in causation of cerebrovascular accidents. J Heart Lung Transplant 28:S285
Boehme AK, Pamboukian SV, George JF et al (2017) Anticoagulation control in patients with ventricular assist devices. ASAIO J 63:759–765
Boyle AJ, Russell DR, Teuteberg JJ et al (2009) Low thromboembolism and pump thrombosis with the Heart Mate II left ventricular assist device: analysis of outpatient anticoagulation. J Heart Lung Transplant 28:881–887
Carrel A, Lindbergh C (1935) The culture of whole organs. Science 81:25–41
Centofanti P, Baronetto A, Attisani M et al (2017) Thrombosis in left ventricular assistance device with centrifugal technology: is early thrombolysis a better solution? Int J Artif Organs 40:629–635
Chinn R, Dembitsky W, Eaton L et al (2005) Multicenter experience: prevention and management of left ventricular assist device infections. ASAIO J 51:461–470
Dandel M, Hetzer R (2018) Temporary assist device support for the right ventricle: pre-implant and post implant challenges. Heart Fail Rev. 2018;23:157–171
DeBakey M (1971) Left ventricular bypass pump for cardiac assistance. Am J Cardiol 27:3
Deng MC, Loebe M, El-Banayosy A et al (2001) Mechanical circulatory support for advanced heart failure. Effect of patient selection on outcome. Circulation 103:231–237
Dew M, Kormos R, Roth L (1993) Life quality in the era of bridging to cardiac transplantation: bridge patients in an outpatient setting. ASAIO J 39:145
Fang JC (2009) Rise of the machines – left ventricular assist devices as permanent therapy for advanced heart failure. N Engl J Med 361:1–3
Fitzpatrick JR, Frederick JR, Hsu VM et al (2008) Risk score derived from pre-operative data analysis predicts the need for biventricular mechanical circulatory support. J Heart Lung Transplant 27:1286–1292
Frazier O, Kirklin JK (Hrsg) (2006) ISHLT monograph series. Mechanical circulatory support, Bd I. Elsevier Inc.
Frazier O, Duncan J, Radovanevic B et al (1992) Successful bridge to heart transplantation with a new left ventricular assist device. J Heart Lung Transplant 11:530
Geisen U, Heilmann C, Beyersdorf F et al (2008) Non-surgical bleeding in patients with ventricular assist devices could be explained by acquired von Willebrand disease. Eur J Cardiothorac Surg 33:679–684
Goubergrits L, Affeld K (2004) Numerical estimation of blood damage in artificial organs. Artif Organs 28:499–507
Haberl T, Riebandt J, Mahr S et al (2014) Viennese approach to minimize the invasiveness of ventricular assist device implantation. Eur J Cardiothorac Surg 46:991–996
Haj-Yahia S, Birks E, Rogers P et al (2007) Midterm reliability with the Jarvik 2000 axial flow left ventricular assist device. J Thorac Cardiovasc Surg 134:199–203
Hetzer R, Potapov EV, Huebler S (2006) Procedings of the 4th Berlin symposium on mechanical circulatory support. J Card Surg 21:512–520
Hill J, Farrar D, Hershon J et al (1986) Use of a prosthetic ventricle as a bridge to cardiac transplantation for postinfarction cardiogenic shock. N Engl J Med 314:626
Hoefer D, Poelzl G, Kilo J et al (2005) Early detection and successful therapy of fulminant chlamydia pneumoniae myocarditis. ASAIO J 51:480–481
Hoefer D, Ruttmann E, Poelzl G et al (2006) Outcome evaluation of the bridge to bridge concept in patients with cardiogenic shock. Ann Thorac Surg 82:28–34
Hoefer D, Velik-Salchner C, Antretter H (2014) Increase in left ventricular assist device thrombosis. Letter to the editor. N Engl J Med 370:1464
Höfer D, Antretter H, Laufer G (2007) Klinische Indikationskriterien für mechanische Kreislaufunterstützung. Z Herz Thorax Gefäßchir 21:273–279
Holman WA, Teitel ER, Itescu S (2006) Chapter 2: Biologic barriers to mechanical circulatory support. ISHLT Monograph Series 1:9–32
John R (2008) Current axial-flow devices – the HeartMate® II and Jarvik 2000 left ventricular assist devices. Semin Thorac Cardiovasc Surg 20:264–272
Kambic HE, Nose Y (1991) Biomaterial for blood pumps. Aus: Blood compatible materials and devices: perspectives towards the 21st century. Technomic Publishing Co. Inc, Lancaster, S 141–151
Kavarana MN, Pessin-Minsley MS, Urtecho J et al (2002) Right ventricular dysfunction and organ failure in left ventricular assist device recipients: a continuing problem. Ann Thorac Surg 73:745–750
Kim YI, Ferdinande P, Flameng W, Daenen W (1995) Isolated right ventricular unloading for postcardiotomy right ventricular failure in a child. Eur J Cardiothorac Surg 9:169–171
Kirklin JK, Naftel DC, Kormos RL et al (2010) Second INTERMACS annual report: More than 1000 primary left ventricular assist device implants. J Heart Lung Transplant 29:1–10
Kirklin JK, Pagani FD, Kormos RL et al (2017) Eighth annual INTERMACS report: Special focus on framing the impact of adverse events. J Heart Lung Transplant 36:1080–1086
Klovaite J, Gustafson F, Mortensen SA et al (2009) Severely impaired von Willebrand factor-dependent platelet aggregation in patients with a continuous-flow left ventricular assist device (Heart Mate II). J Am Coll Cardiol 53:2162–2167
Krabatsch T, Henning E, Stepananko A et al (2011) Evaluation of the HeartWare HVAD centrifugal pump for right ventricular assistance in an in vitro model. ASAIO J 57:183–187
Ledford ID, Miller DV, Mason NO et al (2011) Differential infection rates between velours versus silicone interface at the Heart Mate II Driveline exit site: structural and ultrastructural insight into possible causes. J Heart Lung Transplant 30:S10
LeGallois C (1813) Experiences on the principle of life. Thomas, Philadelphia
Levy WC, Mozaffarin D, Linker DT et al (2006) The Seattle heart failure model: prediction of survival in heart failure. Circulation 113:1424–1433
Levy WC, Mozaffarin D, Linker DT et al (2009) Can the Seattle heart failure model be used to risk-stratify heart failure patients for potential left ventricular assist device therapy? J Heart Lung Transplant 28:231–236
Magliato KE, Kleisli T, Soukiasian HJ et al (2003) Biventricular support in patients with profound cardiogenic shock: a single center experience. ASAIO J 49:475–479
Martinez BK, Yik B, Tran R et al (2018) Meta-Analysis of time in therapeutic range in continuous-flow left ventricular assist device patients receiving warfarin. Artif Organs. 2018;42:700–704
Matthews JC, Koelling TM, Pagani FD, Aaronson KD (2008) The right ventricular failure risk score: a pre-operative tool for assessing the risk of right ventricular failure in left ventricular assist device candidates. J Am Coll Cardiol 51:2163–2172
McKinlay SM, Sleeper L, Waclawiw M et al (1995) Evaluation of an implantable ventricular assist system for humans with chronic refractory heart failure: designing a randomized trial. ASAIO J 41:16
Mehra MR, Naka Y, Uriel N et al (2017) A fully magnetically levitated circulatory pump for advanced heart failure. N Engl J Med 376:440–450
Miera O, Potapov EV, Redlin M, Stepanenko A, Berger F, Hetzer R, Hübler M (2011) First experiences with the HeartWare ventricular assist system in children. Ann Thorac Surg 91:1256–1260
Mikus E, Stepanenko A, Krabatsch T et al (2011) [Reversibility of fixed pulmonary hypertension in left ventricular assist device support recipients. Eur J Cardiothorac Surg. 2011;40:971–977
Miller LW, Pagani FD, Russell SD et al (2007) Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med 357:885–896
Moazami N, Pasque MK, Moon MR et al (2004) Mechanical support for isolated right ventricular failure in patients after cardiotomy. J Heart Lung Transplant 23:1371–1375
Muslem R, Caliskan K, Leebeek FW (2018) Acquired coagulopathy in patients with left ventricular assist devices. J Thromb Haemost 16:429–440
Nair PK, Kormos RL, Teuteberg JJ et al (2010) Pulsatile left ventricular assist device support as a bridge to decision in patients with end-stage heart failure complicated by pulmonary hypertension. J Heart Lung Transplant 29:201–218
Nascimbene A, Neelamegham S, Frazier OH et al (2016) Acquired von Willebrand syndrome associated with left ventricular assist device. Blood 25:3133–3141
Ochiai Y, McCarthy PM, Smerida NG et al (2002) Predictors of severe right ventricular failure after implantable left ventricular assist device insertion: analysis of 245 patients. Circulation 106(Suppl I):198–202
Pagani FD, Aaronson KD, Swaniker F, Bartlett RH (2001) The use of extracorporeal life support in adult patients with primary cardiac failure as a bridge to implantable left ventricular assist device. Ann Thorac Surg 71:77–81
Pagani FD, Miller LW, Russell SD et al (2009) Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device. J Am Coll Cardiol 54:312–321
Park SJ, Milano CA, Rogers JG et al (2012) Outcomes in advanced heart failure patients with left ventricular assist devices for destination therapy. Circ Heart Fail 5:241–248
Pennington DG, Griffith BP, McKinlay SM et al (1995) Evaluation of an implantable ventricular assist system for humans with chronic refractory heart failure: study overview. ASAIO J 41:11–15
Pinney SP, Anyanwu AC, Lala A et al (2017) Left ventricular assist devices for lifelong support. J Am Coll Cardiol 69:2845–2861
Portner P, Oyer P, McGregor C (1985) First human use of an electrically powered implantable ventricular assist system. Artif Organs 9:36
Riebandt J, Sandner S, Mahr S et al (2013) Minimally invasive Thoratec HeartMate II implantation in the setting of severe thoracic aortic calcification. Ann Thorac Surg 96:1094–1096
Riebandt J, Haberl T, Mahr S et al (2014) Preoperative patient optimization using extracorporeal life support improves outcomes of INTERMACS level I patients receiving a permanent ventricular assist device. Eur J Cardiothorac Surg 46:486–492
Rogers JG, Pagani FD, Tatooles AJ et al (2017) Intrapericardial left ventricular assist device for advanced heart failure. N Engl J Med 376:451–460
Rose E, Gelijns A, Moskowitz A et al (2001) Long-term mechanical left ventricular assistance for end-stage heart failure. N Engl J Med 345:1435–1443
Saxton G, Andrews C (1960) An ideal pump with hydrodynamic characteristics analogous to the mammalian heart. Trans Am Soc Artif Intern Organs 6:288
Slaughter MS, Rogers JG, Milano CA et al (2009) Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med 361:2241–2251
Slaughter MS, Pagani FD, Rogers JG et al (2010) Clinical management of continuous-flow left ventricular assist devices in advanced heart failure. J Heart Lung Transplant 29:4S
Spanier TB, Oz M, Levin H et al (1996a) Activation of coagulation and fibrinolytic pathways in patients with left ventricular assist devices. J Thorac Cardiovasc Surg 112:1090–1097
Spanier TB, Rose EA, Schmidt AM et al (1996b) Interactions between dendritic cells and T cells on the surface of left ventricular assist devices leads to a TH2 pattern of cytokine production and B cell hyperreactivity in vitro. Circulation 94:1704
Stulak JM, Griffith KE, Nicklas JM, Pagani FD (2011) The use of the HeartWare HVAD for long-term right ventricular support after implantation of the HeartMate® II device. J Thorac Cardiovasc Surg. 2011;142:e140–2
Tsubota H, Ribeiro RV, Billia F et al (2017) Left ventricular assist device exchange: the Toronto General Hospital experience. Can J Surg 60:253–259
Tsukui H, Teuteberg JT, McNamarra DM (2005) Biventricular assist device utilization for patients with morbid congestive heart failure: a justifiable strategy. Circulation 112:565–572
Tulchinsky M (2008) Lower gastrointestinal bleeding diagnosed by red blood cell scintigraphy in a patient with a left ventricular assist device. Clin Nucl Med 33:856–858
Velik-Salchner C, Hoermann C, Hoefer D, Margreiter J, Mair P (2009) Thromboembolic complications during weaning from right ventricular assist device support. Anaesth Analg 109:354–357
Wampler R, Moise J, Frazier O et al (1988) In vivo evaluation of a peripheral vascular access axial flow blood pump. ASAIO J 34:450
Westaby S, Banning AP, Saito S et al (2002) Circulatory support for long-term treatment of heart failure: experience with an intraventricular continuous flow pump. Circulation 105:2588–2591
Wheeldon DR, LaForge DH, Lee J et al (2002) Novacor left ventricular assist system long-term performance: comparison of clinical experience with demonstrated in vitro reliability. ASAIO J 48:546–551
Wieselthaler GM, O Driscoll G, Jansz P et al (2010) Initial clinical experience with a novel left ventricular assist device with a magnetically levitated rotor in a multi-institutional trial. J Heart Lung Transplant 29:1218–1225
Williams MR, Oz MC (2001) Indications and patient selection for mechanical ventricular assistance. Ann Thorac Surg 71:S86–S91
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer-Verlag GmbH Austria, ein Teil von Springer Nature
About this chapter
Cite this chapter
Höfer, D., Antretter, H. (2020). Ventrikuläre Unterstützungssysteme. In: Stanger, O. (eds) Kompendium der modernen Herzchirurgie beim Erwachsenen. Springer, Vienna. https://doi.org/10.1007/978-3-7091-0451-4_14
Download citation
DOI: https://doi.org/10.1007/978-3-7091-0451-4_14
Published:
Publisher Name: Springer, Vienna
Print ISBN: 978-3-7091-0450-7
Online ISBN: 978-3-7091-0451-4
eBook Packages: Medicine (German Language)